# EDGAR Filing Document

**Accession Number:** 0001544328
**File Stem:** 0001072613-25-000670
**Filing Date:** 2025-8
**Character Count:** 41979
**Document Hash:** bdd043ea2485afffc7a944867a0a8c8a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001072613-25-000670.hdr.sgml**: 20250819

**ACCESSION NUMBER**: 0001072613-25-000670

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 4

**FILED AS OF DATE**: 20250819

**DATE AS OF CHANGE**: 20250819

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Adaptimmune Therapeutics PLC
- **CENTRAL INDEX KEY:** 0001621227
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** X0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-88833
- **FILM NUMBER:** 251233431

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 60 JUBILEE AVENUE
- **STREET 2:** MILTON PARK
- **CITY:** ABINGDON, OXFORDSHIRE
- **PROVINCE COUNTRY:** X0
- **BUSINESS PHONE:** 44 1235 430000

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 60 JUBILEE AVENUE
- **STREET 2:** MILTON PARK
- **CITY:** ABINGDON, OXFORDSHIRE
- **PROVINCE COUNTRY:** X0

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Adaptimmune Ltd
- **DATE OF NAME CHANGE:** 20141001
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** New Enterprise Associates 14, L.P.
- **CENTRAL INDEX KEY:** 0001544328

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** 1954 GREENSPRING DRIVE
- **STREET 2:** SUITE 600
- **CITY:** TIMONIUM
- **STATE:** MD
- **ZIP:** 21093
- **BUSINESS PHONE:** 410-842-4000

**MAIL ADDRESS:**
- **STREET 1:** 1954 GREENSPRING DRIVE
- **STREET 2:** SUITE 600
- **CITY:** TIMONIUM
- **STATE:** MD
- **ZIP:** 21093

## Ex-1

**<u>EXHIBIT 1</u>**

**AGREEMENT**

Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of stock of Adaptimmune Therapeutics Plc.

EXECUTED this 19<sup>th</sup> day of August, 2025.

NEW ENTERPRISE ASSOCIATES 14, L.P.

By: NEA PARTNERS 14, L.P.<br> General Partner

By: NEA 14 GP, LTD<br> General Partner

&nbsp;&nbsp;&nbsp;&nbsp;By: <u>\*</u> 

Anthony A. Florence, Jr.

Managing Partner and Co-Chief Executive Officer

&nbsp;&nbsp;&nbsp;&nbsp;By: <u>\*</u> 

Mohamad H. Makhzoumi

Managing Partner and Co-Chief Executive Officer

NEA PARTNERS 14, L.P.

By: NEA 14 GP, LTD<br> General Partner

&nbsp;&nbsp;&nbsp;&nbsp;By: <u>\*</u> 

Anthony A. Florence, Jr.

Managing Partner and Co-Chief Executive Officer

&nbsp;&nbsp;&nbsp;&nbsp;By: <u>\*</u> 

Mohamad H. Makhzoumi

Managing Partner and Co-Chief Executive Officer

NEA 14 GP, LTD

By: <u>\*</u> 

&nbsp;&nbsp;&nbsp;&nbsp;Anthony A. Florence, Jr.

&nbsp;&nbsp;&nbsp;&nbsp;Managing Partner and Co-Chief Executive Officer

By: <u>\*</u> 

&nbsp;&nbsp;&nbsp;&nbsp;Mohamad H. Makhzoumi

&nbsp;&nbsp;&nbsp;&nbsp;Managing Partner and Co-Chief Executive Officer

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>\*</u> 

Forest Baskett

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>\*</u> 

Anthony A. Florence, Jr.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>\*</u> 

Patrick J. Kerins

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>\*</u> 

Scott D. Sandell

NEW ENTERPRISE ASSOCIATES 16, L.P.

By: NEA PARTNERS 16, L.P.<br> General Partner

By: NEA 16 GP, LLC<br> General Partner

&nbsp;&nbsp;&nbsp;&nbsp;By: <u>\*</u> 

Anthony A. Florence, Jr.

Managing Partner and Co-Chief Executive Officer

&nbsp;&nbsp;&nbsp;&nbsp;By: <u>\*</u> 

Mohamad H. Makhzoumi

Managing Partner and Co-Chief Executive Officer

NEA PARTNERS 16, L.P.

By: NEA 16 GP, LLC<br> General Partner

&nbsp;&nbsp;&nbsp;&nbsp;By: <u>\*</u> 

Anthony A. Florence, Jr.

Managing Partner and Co-Chief Executive Officer

&nbsp;&nbsp;&nbsp;&nbsp;By: <u>\*</u> 

Mohamad H. Makhzoumi

Managing Partner and Co-Chief Executive Officer

NEA 16 GP, LLC

By: <u>\*</u> 

&nbsp;&nbsp;&nbsp;&nbsp;Anthony A. Florence, Jr.

&nbsp;&nbsp;&nbsp;&nbsp;Managing Partner and Co-Chief Executive Officer

By: <u>\*</u> 

&nbsp;&nbsp;&nbsp;&nbsp;Mohamad H. Makhzoumi

&nbsp;&nbsp;&nbsp;&nbsp;Managing Partner and Co-Chief Executive Officer

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>\*</u> 

Forest Baskett

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>\*</u> 

Ali Behbahani

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>\*</u> 

Carmen Chang

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>\*</u> 

Anthony A. Florence, Jr.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>\*</u> 

Mohamad H. Makhzoumi

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>\*</u> 

Scott D. Sandell

EXECUTIVE COMMITTEE:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>\*</u> 

Mohamad H. Makhzoumi

\*<u>/s/ Zachary Bambach</u> 

Zachary Bambach

As attorney-in-fact

This Agreement relating to Schedule 13D was executed by Zachary Bambach on behalf of the individuals listed above pursuant to a Power of Attorney a copy of which is attached hereto as Exhibit 3.

## Ex-2

**<u>EXHIBIT 2</u>**

**SCHEDULE A**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;**Transaction<br> Date** | **Nature of<br> Transaction** | &nbsp;&nbsp;**Quantity**<br> **(NEA 14)<sup>(1)** | &nbsp;&nbsp;**Quantity<br> (NEA 16)<sup>(2)</sup>** | &nbsp;&nbsp;**Weighted<br> Average Price<br> Per ADS<sup>(3), (4)</sup>** | &nbsp;&nbsp;**Price Range<sup>(4)</sup>** | &nbsp;&nbsp;**Price Range<sup>(4)</sup>** |
| &nbsp;&nbsp;**Transaction<br> Date** | **Nature of<br> Transaction** | &nbsp;&nbsp;**Quantity**<br> **(NEA 14)<sup>(1)** | &nbsp;&nbsp;**Quantity<br> (NEA 16)<sup>(2)</sup>** | &nbsp;&nbsp;**Weighted<br> Average Price<br> Per ADS<sup>(3), (4)</sup>** | &nbsp;&nbsp;**Minimum** | &nbsp;&nbsp;**Maximum** |
| &nbsp;&nbsp;August 15, 2025 | Open Market Sale | &nbsp;&nbsp;3424255<br> (20545530) | &nbsp;&nbsp;804701<br> (4828206) | &nbsp;&nbsp;$0.0662 | &nbsp;&nbsp;$0.0595 | &nbsp;&nbsp;$0.0708 |
| &nbsp;&nbsp;August 18, 2025 | Open Market Sale | &nbsp;&nbsp;10405523<br> (62433138) | &nbsp;&nbsp;2445299<br> (14671794) | &nbsp;&nbsp;$0.0722 | &nbsp;&nbsp;$0.0685 | &nbsp;&nbsp;$0.0685 |

---

_______________________________

(1) The
 quantities reported in this column are in the form of American Depositary Shares ("ADSs"),
 with the number of Ordinary Shares represented thereby noted in parentheses. The ADSs are
 held of record by New Enterprise Associates 14, L.P. ("NEA 14") and each ADS
 represents six Ordinary Shares.

(2) The
 quantities reported in this column are in the form of ADSs, with the number of Ordinary Shares
 represented thereby noted in parentheses. The ADSs are held of record by New Enterprise Associates
 16, L.P. ("NEA 16") and each ADS represents six Ordinary Shares.

(3) The
 Reporting Persons undertake to provide to the Securities and Exchange Commission staff, upon
 request, full information regarding the number of shares purchased at each price within the
 ranges set forth in the table above.

(4) The
 prices reported in this column are in the form of price per ADS.

## Ex-3

**<u>EXHIBIT 3</u>**

**POWER OF ATTORNEY**

KNOW ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Zachary Bambach, Nicole Hatcher and Stephanie Brecher, and each of them, with full power to act without the others, his or her true and lawful attorney-in-fact, with full power of substitution, to sign any and all instruments, certificates and documents that may be necessary, desirable or appropriate to be executed on behalf of himself as an individual or in his or her capacity as a direct or indirect general partner, director, officer or manager of any partnership, corporation or limited liability company, pursuant to section 13 or 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and any and all regulations promulgated thereunder, including, without limitation, Forms 3, 4 and 5 and Schedules 13D and 13G (and any amendments thereto), and to file the same, with all exhibits thereto, and any other documents in connection therewith, with the Securities and Exchange Commission (the "SEC"), including, but not limited to, signing a Form ID for and on behalf of the undersigned and filing such Form ID with the SEC, and with any other entity when and if such is mandated by the Exchange Act or by the Financial Industry Regulatory Authority, granting unto said attorney-in-fact full power and authority to do and perform each and every act and thing necessary, desirable or appropriate, fully to all intents and purposes as he or she might or could do in person, thereby ratifying and confirming all that said attorney-in-fact, or his or her substitutes, may lawfully do or cause to be done by virtue hereof. This power of attorney is perpetual, unless revoked by the undersigned in a signed writing delivered to each of the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, this Power of Attorney has been signed as of the 29th day of February, 2024.

---

| |
|:---|
| /s/ Peter J. Barris |
| Peter J. Barris |
| /s/ Forest Baskett |
| Forest Baskett |
| /s/ Ali Behbahani |
| Ali Behbahani |
| /s/ Ronald D. Bernal |
| Ronald D. Bernal |
| /s/ Ann Bordetsky |
| Ann Bordetsky |
| /s/ Carmen Chang |
| Carmen Chang |
| /s/ Philip Chopin |
| Philip Chopin |
| /s/ Anthony A. Florence, Jr. |
| Anthony A. Florence, Jr. |
| /s/ Jonathan Golden |
| Jonathan Golden |
| /s/ Scott Gottlieb |
| Scott Gottlieb |

---

---

| |
|:---|
| /s/ Mark Hawkins |
| Mark Hawkins |
| /s/ Jeffrey R. Immelt |
| Jeffrey R. Immelt |
| /s/ Aaron Jacobson |
| Aaron Jacobson |
| /s/ Patrick J. Kerins |
| Patrick J. Kerins |
| /s/ Hilarie Koplow-McAdams |
| Hilarie Koplow-McAdams |
| /s/ Vanessa Larco |
| Vanessa Larco |
| /s/ Julio C. Lopez |
| Julio C. Lopez |
| /s/ Tiffany Le |
| Tiffany Le |
| /s/ Mohamad H. Makhzoumi |
| Mohamad H. Makhzoumi |
| /s/ Edward T. Mathers |
| Edward T. Mathers |
| /s/ Gregory Papadopoulos |
| Gregory Papadopoulos |
| /s/ Kavita Patel |
| Kavita Patel |
| /s/ Scott D. Sandell |
| Scott D. Sandell |
| /s/ A. Brooke Seawell |
| A. Brooke Seawell |
| /s/ Peter Sonsini |
| Peter Sonsini |
| /s/ Melissa Taunton |
| Melissa Taunton |
| /s/ Paul E. Walker |
| Paul E. Walker |
| /s/ Rick Yang |
| Rick Yang |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 3)**

**Adaptimmune Therapeutics Plc**

*(Name of Issuer)*

**Ordinary Shares, (pound).001 par value per share**

*(Title of Class of Securities)*

**00653A107**

*(CUSIP Number)*

**Stephanie Brecher**<br>New Enterprise Associates<br>1954 Greenspring Drive, Suite 600<br>Timonium MD 21093<br>(410) 842-4000

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**08/15/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **00653A107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**New Enterprise Associates 14, L.P.** | Name of reporting person<br>**New Enterprise Associates 14, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**CAYMAN ISLANDS** | Citizenship or place of organization<br>**CAYMAN ISLANDS** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**4.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**4.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**4.00** | Aggregate amount beneficially owned by each reporting person<br>**4.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0%** | Percent of class represented by amount in Row (11)<br>**0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **00653A107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**NEA Partners 14, L.P.** | Name of reporting person<br>**NEA Partners 14, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**CAYMAN ISLANDS** | Citizenship or place of organization<br>**CAYMAN ISLANDS** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**4.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**4.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**4.00** | Aggregate amount beneficially owned by each reporting person<br>**4.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0%** | Percent of class represented by amount in Row (11)<br>**0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **00653A107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**NEA 14 GP, LTD** | Name of reporting person<br>**NEA 14 GP, LTD** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**CAYMAN ISLANDS** | Citizenship or place of organization<br>**CAYMAN ISLANDS** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**4.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**4.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**4.00** | Aggregate amount beneficially owned by each reporting person<br>**4.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0%** | Percent of class represented by amount in Row (11)<br>**0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**CO** | Type of Reporting Person (See Instructions)<br>**CO** | |

---

| **CUSIP No.** | **00653A107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**New Enterprise Associates 16, L.P.** | Name of reporting person<br>**New Enterprise Associates 16, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**4.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**4.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**4.00** | Aggregate amount beneficially owned by each reporting person<br>**4.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0%** | Percent of class represented by amount in Row (11)<br>**0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **00653A107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**NEA Partners 16, L.P.** | Name of reporting person<br>**NEA Partners 16, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**4.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**4.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**4.00** | Aggregate amount beneficially owned by each reporting person<br>**4.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0%** | Percent of class represented by amount in Row (11)<br>**0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **00653A107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**NEA 16 GP, LLC** | Name of reporting person<br>**NEA 16 GP, LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**4.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**4.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**4.00** | Aggregate amount beneficially owned by each reporting person<br>**4.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0%** | Percent of class represented by amount in Row (11)<br>**0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

| **CUSIP No.** | **00653A107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Forest Baskett** | Name of reporting person<br>**Forest Baskett** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**4.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**4.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**4.00** | Aggregate amount beneficially owned by each reporting person<br>**4.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0%** | Percent of class represented by amount in Row (11)<br>**0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

| **CUSIP No.** | **00653A107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Anthony A. Florence, Jr.** | Name of reporting person<br>**Anthony A. Florence, Jr.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**4.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**4.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**4.00** | Aggregate amount beneficially owned by each reporting person<br>**4.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0%** | Percent of class represented by amount in Row (11)<br>**0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

| **CUSIP No.** | **00653A107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Patrick J. Kerins** | Name of reporting person<br>**Patrick J. Kerins** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**4.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**4.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**4.00** | Aggregate amount beneficially owned by each reporting person<br>**4.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0%** | Percent of class represented by amount in Row (11)<br>**0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

| **CUSIP No.** | **00653A107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Mohamad H. Makhzoumi** | Name of reporting person<br>**Mohamad H. Makhzoumi** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**4.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**4.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**4.00** | Aggregate amount beneficially owned by each reporting person<br>**4.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0%** | Percent of class represented by amount in Row (11)<br>**0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

| **CUSIP No.** | **00653A107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Scott D. Sandell** | Name of reporting person<br>**Scott D. Sandell** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**4.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**4.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**4.00** | Aggregate amount beneficially owned by each reporting person<br>**4.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0%** | Percent of class represented by amount in Row (11)<br>**0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Ordinary Shares, (pound).001 par value per share

**(b) Name of Issuer:**
Adaptimmune Therapeutics Plc

**(c) Address of Issuer's Principal Executive Offices:**
60 Jubilee Avenue, Milton Park, Abingdon, Oxfordshire, X0, OX14 4RX

This Amendment No. 3 ("Amendment No. 3") to Schedule 13D amends the Schedule 13D originally filed on September 17, 2018 (the "Schedule 13D"), Amendment No. 1 thereto filed on March 30, 2023 ("Amendment No. 1") and Amendment No. 2 thereto filed on April 2, 2024 ("Amendment No. 2"), and relates to the ordinary shares, (pound).001 par value (the "Ordinary Shares"), including Ordinary Shares represented by American Depositary Shares (the "ADS"), with each ADS representing six Ordinary Shares, of the Issuer.

Certain terms used but not defined in this Amendment No. 3 have the meanings assigned thereto in the Schedule 13D (including Amendment No. 1 and Amendment No. 2 thereto). Except as specifically provided herein, this Amendment No. 3 does not modify any of the information previously reported on the Schedule 13D (including Amendment No. 1 and Amendment No. 2 thereto).

**Item 4. Purpose of Transaction**

Schedule A attached hereto as Exhibit 2 describes all transactions in the Issuer's Ordinary Shares that were effected by the Reporting Persons during the past 60 days. Depending on market conditions and other factors, the Funds and other Reporting Persons may dispose of additional shares of the Issuer.

**Item 5. Interest in Securities of the Issuer**

**(a)**
As of August 18, 2025, NEA 14 is the record owner of 4 Ordinary Shares (the "NEA 14 Shares"). As the general partner of NEA 14, NEA Partners 14 may be deemed to own beneficially the NEA 14 Shares. As the sole general partner of NEA Partners 14, NEA 14 GP may be deemed to own beneficially the NEA 14 Shares. As directors of NEA 14 GP each of the Dual Managers and the NEA 14 Director may be deemed to own beneficially the NEA 14 Shares. As an individual member of the Executive Committee, which committee has been delegated certain approval rights with respect to dispositions of the NEA 14 Shares, Makhzoumi may also be deemed to own beneficially the NEA 14 Shares.

As of August 18, 2025, NEA 16 is the record owner of 0 Ordinary Shares.

Collectively, the Funds now hold a total of 4 Ordinary Shares (the "Firm Shares"). By virtue of their relationship as affiliated entities, whose controlling entities have substantially overlapping individual controlling persons, each of the Funds and the Control Entities may be deemed to share the power to direct the disposition and vote of the Firm Shares.

Each Reporting Person disclaims beneficial ownership of the Firm Shares other than those shares which such person owns of record.

The percentage of outstanding Ordinary Shares of the Issuer which may be deemed to be beneficially owned by each Reporting Person is set forth on Line 13 of such Reporting Person's cover sheet. Such percentage was calculated for each Reporting Person based on the 1,590,309,546 Ordinary Shares reported by the Issuer to be outstanding as of August 11, 2025, on the Issuer's Form 10-Q filed with the Securities and Exchange Commission on August 13, 2025.

**(b)**
Regarding the number of shares as to which such person has:

(i) sole power to vote or to direct the vote: See line 7 of cover sheets

(ii) shared power to vote or to direct the vote: See line 8 of cover sheets

(iii) sole power to dispose or to direct the disposition: See line 9 of cover sheets

(iv) shared power to dispose or to direct the disposition: See line 10 of cover sheets.

**(c)**
Schedule A attached hereto as Exhibit 2 describes all transactions in the Issuer's Ordinary Shares that were effected by the Reporting Persons during the past 60 days.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Not applicable.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** New Enterprise Associates 14, L.P.

**Signature:** /s/ Zachary Bambach

**Name/Title:** Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Managing Partner and Co-Chief Executive Officer

**Date:** 08/19/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** NEA Partners 14, L.P.

**Signature:** /s/ Zachary Bambach

**Name/Title:** Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Managing Partner and Co-Chief Executive Officer

**Date:** 08/19/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** NEA 14 GP, LTD

**Signature:** /s/ Zachary Bambach

**Name/Title:** Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Managing Partner and Co-Chief Executive Officer

**Date:** 08/19/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** New Enterprise Associates 16, L.P.

**Signature:** /s/ Zachary Bambach

**Name/Title:** Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Managing Partner and Co-Chief Executive Officer

**Date:** 08/19/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** NEA Partners 16, L.P.

**Signature:** /s/ Zachary Bambach

**Name/Title:** Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Managing Partner and Co-Chief Executive Officer

**Date:** 08/19/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** NEA 16 GP, LLC

**Signature:** /s/ Zachary Bambach

**Name/Title:** Zachary Bambach as attorney-in-fact for Anthony A. Florence Jr., Managing Partner and Co-Chief Executive Officer

**Date:** 08/19/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Forest Baskett

**Signature:** /s/ Zachary Bambach

**Name/Title:** Zachary Bambach as attorney-in-fact for Forest Baskett

**Date:** 08/19/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Anthony A. Florence, Jr.

**Signature:** /s/ Zachary Bambach

**Name/Title:** Zachary Bambach as attorney-in-fact for Anthony A. Florence, Jr.

**Date:** 08/19/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Patrick J. Kerins

**Signature:** /s/ Zachary Bambach

**Name/Title:** Zachary Bambach as attorney-in-fact for Patrick J. Kerins

**Date:** 08/19/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Mohamad H. Makhzoumi

**Signature:** /s/ Zachary Bambach

**Name/Title:** Zachary Bambach as attorney-in-fact for Mohamad H. Makhzoumi

**Date:** 08/19/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Scott D. Sandell

**Signature:** /s/ Zachary Bambach

**Name/Title:** Zachary Bambach as attorney-in-fact for Scott D.Sandell

**Date:** 08/19/2025